CCNA2 as an Immunological Biomarker Encompassing Tumor Microenvironment and Therapeutic Response in Multiple Cancer TypesAimin Jiang, Linhui Wang, Xinxin Gan et al.|Oxidative Medicine and Cellular Longevity|2022Cited by 65
Elevated SNRPA1, as a Promising Predictor Reflecting Severe Clinical Outcome via Effecting Tumor Immunity for ccRCC, Is Related to Cell Invasion, Metastasis, and Sunitinib SensitivityAimin Jiang, Linhui Wang, Jialin Meng et al.|Frontiers in Immunology|2022Cited by 25